141 related articles for article (PubMed ID: 20511190)
1. Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas.
Bai R; Siu IM; Tyler BM; Staedtke V; Gallia GL; Riggins GJ
Neuro Oncol; 2010 Jul; 12(7):655-63. PubMed ID: 20511190
[TBL] [Abstract][Full Text] [Related]
2. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.
Di C; Liao S; Adamson DC; Parrett TJ; Broderick DK; Shi Q; Lengauer C; Cummins JM; Velculescu VE; Fults DW; McLendon RE; Bigner DD; Yan H
Cancer Res; 2005 Feb; 65(3):919-24. PubMed ID: 15705891
[TBL] [Abstract][Full Text] [Related]
3. OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells.
Bai RY; Staedtke V; Lidov HG; Eberhart CG; Riggins GJ
Cancer Res; 2012 Nov; 72(22):5988-6001. PubMed ID: 22986744
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567
[TBL] [Abstract][Full Text] [Related]
5. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells.
Bunt J; Hasselt NE; Zwijnenburg DA; Hamdi M; Koster J; Versteeg R; Kool M
Int J Cancer; 2012 Jul; 131(2):E21-32. PubMed ID: 21964830
[TBL] [Abstract][Full Text] [Related]
6. The
Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001
[TBL] [Abstract][Full Text] [Related]
7. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways.
Li J; Di C; Jing J; Di Q; Nakhla J; Adamson DC
Int J Oncol; 2015 Nov; 47(5):1703-10. PubMed ID: 26397460
[TBL] [Abstract][Full Text] [Related]
8. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas.
Adamson DC; Shi Q; Wortham M; Northcott PA; Di C; Duncan CG; Li J; McLendon RE; Bigner DD; Taylor MD; Yan H
Cancer Res; 2010 Jan; 70(1):181-91. PubMed ID: 20028867
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.
Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732
[TBL] [Abstract][Full Text] [Related]
10. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.
de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M
J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208
[TBL] [Abstract][Full Text] [Related]
11. OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells.
Kaur R; Aiken C; Morrison LC; Rao R; Del Bigio MR; Rampalli S; Werbowetski-Ogilvie T
Dis Model Mech; 2015 Oct; 8(10):1295-309. PubMed ID: 26398939
[TBL] [Abstract][Full Text] [Related]
12. Genomic amplification of orthodenticle homologue 2 in medulloblastomas.
Boon K; Eberhart CG; Riggins GJ
Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
Qin N; Paisana E; Picard D; Leprivier G; Langini M; Custódia C; Cascão R; Conrad C; Peitzsch M; Stefanski A; Stühler K; Fischer U; Faria CC; Dietrich S; Reifenberger G; Remke M
J Neurooncol; 2023 Nov; 165(2):329-342. PubMed ID: 37976029
[TBL] [Abstract][Full Text] [Related]
14. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372
[TBL] [Abstract][Full Text] [Related]
15. MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.
Panwalkar P; Moiyadi A; Goel A; Shetty P; Goel N; Sridhar E; Shirsat N
J Mol Neurosci; 2015 Jul; 56(3):673-80. PubMed ID: 25859932
[TBL] [Abstract][Full Text] [Related]
16. Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma.
Wortham M; Guo C; Zhang M; Song L; Lee BK; Iyer VR; Furey TS; Crawford GE; Yan H; He Y
PLoS One; 2014; 9(9):e107156. PubMed ID: 25198066
[TBL] [Abstract][Full Text] [Related]
17. All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line.
Chang Q; Chen Z; You J; McNutt MA; Zhang T; Han Z; Zhang X; Gong E; Gu J
J Neurooncol; 2007 Sep; 84(3):263-7. PubMed ID: 17453147
[TBL] [Abstract][Full Text] [Related]
18. Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA).
Spiller SE; Ditzler SH; Pullar BJ; Olson JM
J Neurooncol; 2008 Apr; 87(2):133-41. PubMed ID: 18060600
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant.
Duplan SM; Théorêt Y; Kenigsberg RL
Clin Cancer Res; 2002 Jan; 8(1):246-57. PubMed ID: 11801566
[TBL] [Abstract][Full Text] [Related]
20. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.
Boulay G; Awad ME; Riggi N; Archer TC; Iyer S; Boonseng WE; Rossetti NE; Naigles B; Rengarajan S; Volorio A; Kim JC; Mesirov JP; Tamayo P; Pomeroy SL; Aryee MJ; Rivera MN
Cancer Discov; 2017 Mar; 7(3):288-301. PubMed ID: 28213356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
